Israel Englander Insmed Inc Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Insmed Inc stock. As of the latest transaction made, Millennium Management LLC holds 679,191 shares of INSM stock, worth $82.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

679,191

Previous 699,006 2.83%

Holding current value

$82.9 Million

Previous $48.3 Million 7.37%

% of portfolio

0.03%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$65.25 - $83.83 $1.29 Million - $1.66 Million	-19,815 Reduced 2.83%	679,191 $51.8 Million
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $8.89 Million - $10.3 Million	134,150 Added 23.75%	699,006 $48.3 Million
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $39.3 Million - $50.1 Million	-633,654 Reduced 52.87%	564,856 $41.2 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $20.3 Million - $64.3 Million	921,892 Added 333.27%	1,198,510 $80.3 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $34.2 Million - $39.8 Million	-1,328,383 Reduced 82.77%	276,618 $7.5 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $35.5 Million - $48.1 Million	1,514,139 Added 1666.42%	1,605,001 $49.7 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $2.58 Million - $3.32 Million	-157,129 Reduced 63.36%	90,862 $1.92 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $4.03 Million - $5.39 Million	247,991 New	247,991 $4.23 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $14.2 Million - $19.2 Million	680,999 Added 284.84%	920,077 $19.8 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $3.18 Million - $4.79 Million	186,407 Added 353.91%	239,078 $4.72 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $211,142 - $290,864	10,340 Added 24.43%	52,671 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $1.1 Million - $1.42 Million	42,331 New	42,331 $1.15 Million
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $263,972 - $346,360	-11,753 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $109,586 - $163,269	4,534 Added 62.81%	11,753 $334,000
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $1.59 Million - $2.19 Million	-49,372 Reduced 87.24%	7,219 $246,000
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $4.3 Million - $5.54 Million	-136,622 Reduced 70.71%	56,591 $1.88 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $2.86 Million - $3.79 Million	-109,965 Reduced 36.27%	193,213 $6.21 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $1.79 Million - $3.74 Million	-127,113 Reduced 29.54%	303,178 $8.35 Million
Q1 2020 May 14, 2020	SELL	$13.63 - $33.98 $5.38 Million - $13.4 Million	-394,419 Reduced 47.83%	430,291 $6.9 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $7.94 Million - $12.3 Million	492,442 Added 148.21%	824,710 $19.7 Million
Q1 2019 May 14, 2019	BUY	$13.91 - $31.15 $4.47 Million - $10 Million	321,153 Added 2889.37%	332,268 $9.66 Million
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $128,934 - $207,850	11,115 New	11,115 $146,000
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $220,559 - $326,823	-11,639 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $232,780 - $345,911	11,639 New	11,639 $275,000
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $507,307 - $771,603	-23,389 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $3.87 Million - $4.65 Million	-146,432 Reduced 86.23%	23,389 $729,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $1.97 Million - $5.3 Million	169,821	169,821 $5.3 Million

Others Institutions Holding INSM

# of Institutions

533

Shares Held

192M

Call Options Held

1.12M

Put Options Held

1.79M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $16.5B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account